Future topics IMI 2 Calls for proposals

The Innovative Medicines Initiative (IMI) has published six topics that are under consideration for inclusion in the Calls for proposals, that will be launched in 2014 under IMI 2. The second call is scheduled for launch in December.  
• RADAR: Remote assessment of disease and relapse;
• Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification;
• Towards a quantitative biological approach for neuropsychiatry;
• The consistency approach to Quality Control in vaccine manufacture;
• Patient knowledge repository to enable patient focused medicine development;
• Pertussis vaccination research.

All information above is indicative and subject to the approval of the IMI 2 legislative package and the agreement of the IMI Governing Board on the Call topics.
The goal of the IMI 2 programme is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI's first phase. As before, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.